Stifel Financial Corp Bolt Biotherapeutics, Inc. Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.27 - $1.95 $15,575 - $23,914	12,264 New	12,264 $15,000
Q4 2022 Feb 13, 2023	SELL	$1.26 - $1.51 $64 - $77	-51 Reduced 0.36%	14,014 $18,000
Q3 2022 Nov 14, 2022	BUY	$1.48 - $2.61 $364 - $642	246 Added 1.78%	14,065 $21,000
Q2 2022 Aug 15, 2022	BUY	$1.41 - $2.91 $26 - $55	19 Added 0.14%	13,819 $28,000
Q1 2022 May 13, 2022	BUY	$2.74 - $4.82 $37,812 - $66,516	13,800 New	13,800 $38,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.